Delivery Order SPE2DB22D3004-SPE2DB25FPT92

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AMNESTEEM 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with a total ceiling value of $2,949.75 and a completion date of September 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $2,253.24 and runs through March 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,422.68, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a period of performance through February 11, 2025 and is a Firm Fixed Price contract type. The contract was not awarded under any set-aside program. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMNESTEEM 40 MG CAPSULE 30S, a generic pharmaceutical product. The contract has a ceiling value of $1,876.08 and runs through February 6, 2025. It is a firm-fixed-price contract, with no set-aside designation indicated. The contract is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,284.46, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,147.68 firm-fixed-price contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of August 22, 2024 and was awarded on August 21, 2022. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $1,511.20 and is a Firm Fixed Price contract. The period of performance extends through August 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AMNESTEEM 40 MG CAPSULE 30S. The contract has a ceiling value of $3,713.75 and is a firm fixed price delivery order contract. This award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm fixed price delivery order with a ceiling value of $4,742.72 and a completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as...
This federal contract award is a delivery order with a ceiling value of $26,184.87 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of AMNESTEEM 40 MG CAPSULE 30S, a medical product, with a performance period through June 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPT92
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AMNESTEEM 40 MG CAPSULE 30S. The contract has a ceiling value of $1,488.16 and runs through March 5, 2025. It is a firm-fixed-price contract, with no set-aside designation indicated.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is likely part of this broader IDC, ensuring efficient government procurement of essential medical commodities for military personnel, veterans, and other federal beneficiaries.

Generated 6/3/25, 9:50 AM